Clinical and Experimental Pediatrics10.3345/cep.2022.002832022656302-303Coronavirus disease 2019 and mRNA vaccines: what’s next – miRNA?Joon Kee Lee, Heon-Seok Han,,
Vaccines10.3390/vaccines100609352022106935Recurring Weakness in Rhabdomyolysis Following Pfizer–BioNTech Coronavirus Disease 2019 mRNA VaccinationMotoya Kimura, Jun-Ichi Niwa, Manabu Doyu
Clinical Infectious Diseases10.1093/cid/ciz743201970122493-2495Pneumococcal Vaccines for Adults: What’s Next?Daniel M Weinberger, Eugene D Shapiro,,
Clinical Infectious Diseases10.1093/cid/ciab06820217371320-1321Accelerate Coronavirus Disease 2019 (COVID-19) Vaccine Rollout by Delaying the Second Dose of mRNA VaccinesStanley A Plotkin, Neal Halsey,,
Nature10.1038/d41586-020-00236-92020578779315-16Coronavirus outbreak: what’s next?Dyani Lewis,,
BMJ10.1136/bmj.m47352020m4735Equitable global access to coronavirus disease 2019 vaccinesJason L Schwartz,
Clinical Infectious Diseases10.1093/cid/ciac2882022Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 (COVID-19) Infection and Severe Disease in SingaporePremikha. M, Calvin J. Chiew, Wycliffe E. Wei, Yee-Sin Leo, Benjamin Ong, David Chien Lye, Vernon J. Lee, Kelvin Bryan Tan,
CNS Spectrums10.1017/s1092852919001032201924S14-13Binge eating disorder revisited: what’s new, what’s different, what’s nextLeslie Citrome
CNS Spectrums10.1017/s1092852919001366201924S182-82Binge eating disorder revisited: what’s new, what’s different, what’s next – AddendumLeslie Citrome
Engineering10.1016/j.eng.2021.04.005202176712-714Coronavirus Variants—Will New mRNA Vaccines Meet the Challenge?Jennifer Welsh,